Skip to main content
HairCited

Minoxidil para Alopecia Areata

A

Baseado em 48 estudos (2 meta-analyses, 1 RCT) com 21,842 participantes no total. 37/48 estudos mostram efeitos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusão

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efeito: None None

População: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None vs: None Outcome: hair regrowth in severe alopecia areata Efeito: None None

População: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Efeito: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None Efeito: None None

População: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Efeito: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi vs: Placebo Efeito: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

Estudos

27416

Participantes

Positive

A

Nota

Referenced Papers

Dermatologic clinics 2025 5 citações
Pediatric dermatology 2025 5 citações
Journal of the … 2025 2 citações
International journal of … 2025 1 citações
Journal of clinical … 2025 1 citações
Archives of dermatological … 2025
International journal of … 2024 39 citações
American family physician 2024 8 citações
Skin health and … 2024 7 citações
Journal of the … 2024 7 citações
The Journal of … 2024 2 citações
Archives of dermatological … 2023 16 citações
The Cochrane database … 2023 2 citações
The Journal of … 2022 170 citações
Journal of the … 2022 90 citações
Dermatology and therapy 2022 43 citações
Skin appendage disorders 2022 7 citações
JAAD case reports 2022 2 citações
The American Journal … 2022 2 citações
Clinical reviews in … 2021 304 citações
Journal of dermatological … 2021 51 citações
Dermatologic therapy 2021 30 citações
American journal of … 2020 127 citações
International journal of … 2020 58 citações
The journal of … 2020 3 citações
The Australasian journal … 2019 152 citações
American journal of … 2019 84 citações
Journal of the … 2019 50 citações
Expert opinion on … 2019 34 citações
Klinicka onkologie : … 2019 11 citações
Journal of the … 2018 114 citações
Dermatology online journal 2018
American family physician 2017 141 citações
American journal of … 2017 32 citações
Actas dermo-sifiliograficas 2017 17 citações
Deutsches Arzteblatt international 2016 99 citações
Current problems in … 2015 322 citações
The Medical clinics … 2015 66 citações
Canadian family physician … 2015 31 citações
The journal of … 2015 25 citações
Current problems in … 2015 18 citações
Der Internist 2015
Lasers in surgery … 2014 243 citações
American journal of … 2014 82 citações
Expert opinion on … 2014 57 citações
Giornale italiano di … 2014 18 citações
Giornale italiano di … 2014
International journal of … 2013 61 citações
Recent patents on … 2011 6 citações
Seminars in cutaneous … 2009 85 citações
American family physician 2009
The Cochrane database … 2008 222 citações
Current opinion in … 2008 31 citações
International journal of … 2007 185 citações
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 citações
Cleveland Clinic journal … 2005
Praxis 2003 28 citações
American family physician 2003 2 citações
American family physician 2003
American journal of … 2000 28 citações
International journal of … 1999 16 citações
Dermatologic clinics 1998 121 citações
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 citações
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

topical:
2-5% solution, twice daily

Limite superior: 5% topical solution

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

Melhor horário: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efeitos Colaterais Relatados

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interações Conhecidas

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Ingestão máxima tolerável: 5% topical solution

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Minoxidil help with Alopecia Areata?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.